FindMyKOL

Ravish Sachar, MD

Basic profile

Rex Hospital

ORCIDNone on fileNPIOn fileSign in to see identifiers
✓ Itemized record
RegionRaleigh, NC · SoutheastSpecialtyInterventional CardiologyFocusCardiology
Active KOLFindMyKOL type: NationalLatest publication2025Online presenceNot yet checkedPayments2021 onwardNIH fundingNot yet indexedWhy? →

Ravish Sachar is a Cardiology physician affiliated with Rex Hospital. OpenAlex indexes 48 publications with 1,706 citations (h-index 19); ClinicalTrials.gov lists 2 registered studies matched to this name.

Overview

Scholarship

indexed output and impact (OpenAlex)
View publications ↓
48publications

Publications indexed by OpenAlex. Counts exclude supporting files.

1,706citations

Citations across these publications.

19h-index

H-index from these publications.

Clinical & industry

trials, payments and federal funding
2clinical trials

Investigator role on registered studies.

View trials ↓
17companies · 2021 onward

Companies reporting payments to CMS. Facts, not judgments.

View payments ↓

Clinical trials

Registered studies on ClinicalTrials.gov where the overall official or a site investigator name-matches this physician, confirmed against known institution/geography. Latest few shown; the full list is part of the full profile.

Industry payments

17 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:

  • Medtronic, Inc.
    Program year202542 payments
    $6,840
  • Boston Scientific
    Program year20254 paymentsResearch
    $1,532
  • AngioDynamics, Inc.
    Program year20251 payment
    $103
All 45 payment records: search, sort and filter.Explore →

Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward. Research funding is listed under each investigator the record names.

Medicare prescribing footprint (2023)

The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.

  • Cardiovascular

    48.6%
    Beta blocker11%
    Metoprolol Succinate63%Metoprolol Tartrate23%Carvedilol14%
    Part D<11 patients
    Statin10.8%
    Atorvastatin Calcium84%Rosuvastatin Calcium16%
    Part D<11 patients

    + 7 more classes in this area

  • Blood & clotting

    47.5%
    P2Y12 inhibitor33.1%
    Clopidogrel100%
    Part D≥79 patients
    Factor Xa inhibitor11.2%
    Eliquis80%Xarelto20%
    Part D<11 patients

    + 1 more class in this area

  • Nervous system

    2.3%
    Gabapentinoids2.3%
    Gabapentin100%
    Part D<11 patients
Where care is delivered (Part B)35.8% facility · 64.2% office

Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.

Publications

Matched to this physician's OpenAlex author record; most-cited works shown first.

Similar KOLs

Other experts from the same institution or the same specialty.

A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet. Reviewed account links and congress post links can appear separately. Absence of a section means “not yet looked,” never “none found.”